management presentation march...

28
MANAGEMENT PRESENTATION MARCH 2019

Upload: others

Post on 07-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

M A N A G E M E N T P R E S E N T A T I O NMARCH 2019

Page 2: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

DISCLAIMER

2

Page 3: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

Today’s agenda

Our Company

Industry Macro Trends

Our Brands

Q318 Financials

01

02

03

04

3

Page 4: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

$80 Billion1

BY 2030

$24 Billion2

PROFIT

$196B

$114B$102B

$80B$75B $71B

$57B$51B

$30B

Froze

n

Alco

ho

l

Ge

ne

ral F

oo

d

Ca

nn

ab

is

Ho

me

Ca

re

He

alth

Re

fridg

era

ted

Be

vera

ge

s

Be

au

ty

Bill

ion

U.S

. D

olla

rs

Cannabis will become a top

consumer category by 20303

1 . COWEN CANNABIS ESTIMATE JANUARY 2019

2. INTERNAL ESTIMATE

3. STATISTA 2017 RETAIL $ VOLUME AND COWEN CANNABIS ESTIMATE JANUARY 20194

T H E O P P O R T U N I T Y

U.S. CANNABIS MARKET IS BECOMING EVEN MORE ATTRACTIVE

Page 5: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

5

REGULATION ACCESS EXPECTATIONS

KEY MACRO TRENDS

Increased regulation

Increased complexity

Ubiquitous retail

9 new states in 2019

Evolving consumer needs

Greater industry expectations

BD I STATES TO WATCH I N 2019

Page 6: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

Our mission is to normalize and

professionalize cannabis

6

Page 7: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

Highly Effective Execution

Scale SellingSystem

House of Brands

Rapid Innovation Capabilities

T H E C R E S C O L A B S A D V A N T A G E

CAPABILITIES TO DRIVE LONG-TERM VALUE

W H A T W E D O H O W W E D O IT

Top-TierManagement Team

7

Page 8: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

U NM AT C H E D SU C C E S S I N

C O M P E T I T I V E ST AT E S

1. We win competitive

licenses to open

new markets

2. We acquire

to enter

existing markets

3. We get to

market

faster

4. We establish

dominant

positions

AC Q U I R E ASSE T S T O D R I V E

GR O W T H AND F O O T P R I NT

O P E R AT I O N A L F AST E R

T H AN C O M P E T I T O R S

AC H I E V E 1 0 0 % P E NE T R AT I O N

AND D O M I NA NT M AR K E T

SH AR E

HIGHLY EFFECTIVE EXECUTION

8

Page 9: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

1. MANAGEMENT ESTIMATES AND SUBJECT TO CLOSING PENDING TRANSACTIONS IN NY, MA & MD

2. MARKET CAP AS OF FEBRUARY 28, 2019

9

ONE OF THE LARGEST OPERATORS IN THE U.S.

Summary Company Information1

Page 10: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

Charles BachtellCEO & COFOUNDER

Joe Caltabiano P RESIDENT & COFOUNDER

Ken Amann CFO

David EllisCOO

Zach Marburger CIO

Jason Erkes CCO

John SchetzGENERAL COUNSEL

Jennifer Clark EVP OP ERATIONS

Emily FitzgeraldDIRECTOR HUMAN RESOURCES

DECADES OF EXPERIENCE WITHIN OUR MANAGEMENT TEAM

Scott WilsonCXO

10

Page 11: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

11

DIVERSITY OF TOP-TIER EXPERIENCES ACROSS THE TEAM

Page 12: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

+120 MillionRESIDENTS

+866 MillionTOURISTS

CURRENT OPERATIONS/LICENSED IN IL, PA, OH, NV, CA, AZ AND NY, MD, AND MA ARE SUBJECT SOLELY TO REGULATORY APPROVAL

PENDING LICENSE APPLICATION MI

MINDY’S EDIBLES LICENSING OPPORTUNITY IN OR, WA, CO, OK, NM

TARGETING EXPANSION IN FL, NJ VA, CT

WE ARE BUILDING SCALE ACROSS THE U.S.

12

Page 13: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

CURRENT PRODUCTION CAPACITY

CULTVATION SQUARE FEET DRY FLOWER ANNUAL CAPACITY (LBS)

TOTAL #

FACILITIES

TOTAL FACILITY

SQUARE FOOTAGECURRENT EXPANSION

TOTAL BY

2019 YECURRENT(5) EXPANSION(5)

TOTAL BY

2019 YE(5)

I L L I N O I S (3) 3 238,000(3) 39,000 100,000 139,000 14,190 53,170 67,360

P E N N S Y L V A N I A (3) 1 118,000(3) 20,000 85,000 105,000 8,250 43,312 51,563

O H I O (2) 1 77,000(3) 25,000 25,000 50,000 9,376 9,543 18,919

C A L I F O R N I A (2) 3 650,000 132,000 460,000 592,000 42,408 140,284 182,692

N E V A D A 1 60,000 N / A 36,000 36,000 N / A 13,578 13,578

A R I Z O N A (1) 2 150,000 128,000 0 128,000 34,265 0 34,265

N E W Y O R K (1) 1 180,000(3) N / A 100,000 100,000 N / A 44,123 44,123

M A S S A C H U S E T T S (1) 1 150,000 13,000 77,000 90,000 5,071 29,968 35,039

T O T A L ( 4 ) 13 1,623,000 357,000 883,000 1,240,000 113,560 333,978 447,539

1. SUBJECT TO CLOSING PENDING TRANSACTIONS.

2. LOCAL APPROVAL RECEIVED, STATE APPROVAL PENDING.

3. SUBJECT TO EXPANSION / CONSTRUCTION.

4. EXCLUDES MARYLAND PROCESSING FACILITY.

5. BASED ON MANAGEMENT ESTIMATES, SUBJECT TO CHANGE

13

Page 14: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

21 retail licenses1

and counting

OWNED RETAIL

1 Includes licenses awarded for additional locations and pending transactions.14

12 current dispensary

locations across 6 states

Page 15: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

IL PA OH NV AZ NY MA TOTAL / AVG

# STORES 5(3) 6(1) 1 1 1(3) 4(3) 3(3) 21

# PATIENTS ( 4 ) 60k 80k 30k(2) N / A 160k 75K 55K 404k

EST. 2020E

PATIENTS250k 250k 150k N / A 200k 250K N / A 1.1M

POPULATION 13M 13M 12M 3M 7M 20M 7M 75M

TOURISTS 114M 40M 43M 43M 44M 244M 28M 556M

M EDICAL Yes Yes Yes Yes Yes Yes Yes N / A

ADULT USE No No No Yes No No Yes N / A

CURRENT RETAIL OPERATIONS

1. REPRESENTS THE NUMBER OF AUTHORIZED POTENTIAL LOCATIONS.

2. MANAGEMENT EXPECTATIONS OF 2019 PATIENT COUNT.

3. SUBJECT TO CLOSING PENDING TRANSACTIONS.

4. MANAGEMENT ESTIMATE BASED ON AVAILABLE STATE DATA15

Page 16: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

Average Revenue Per Square Foot

$6,500(1) $5,546(2) $2,951(2) $2,951(2)

1) CRESCO LABS INTERNAL UNAUDITED ANALYSIS

2) COSTAR RETAIL ANALYSIS JULY 2017

ATTRACTIVE RETAIL PERFORMANCE

16

Page 17: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

We have taken a CPG approach to

building brands

17

Page 18: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

OVERALL MARKET CRESCOLABS BRANDS

CURRENT CONSUMER LANDSCAPE AND PORTFOLIO

M E D I C I N A L

W E L L N E S S /

L I F E S T Y L E

H O L I S T I C

M E D I C I N E

R E G U L A R

L I F E S T Y L E

C O N N O I S S E U R

C R E S C O

R E M E D I R E S E R V E

R E L I E F

R E L I A B L ET R U S T

R E W A R D

18

Page 19: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

19

• BRAND ETHOS: WITH FAMIL IAR FORMATS AND PRECISE

DEL IVERY SYSTEMS, REMEDI PRODUCTS PROVIDE A SAFE,

CONSISTENT AND TRUSTED ALTERNATIVE TO TRADITIONAL

MEDIC INES.

• AUDIENCE: REMEDI WAS DESIGNED AS A REPLACEMENT OPTION

FOR TRADITIONAL MEDICATION TO SUPPORT THE CONSUMER

BASE THAT NEEDS IT ’S CANNABIS TO BE DISCREET, EASILY

IDENTIF IABLE, AND PRECISELY DOSED.

• PRODUCT PILLARS:

-CBD-FORWARD, NON-COMBUSTIBLE

-TRADITIONAL MEDIC INE DOSING FORMATS

-PACKAGING IS DESIGNED TO LOOK L IKE TRADITIONAL

MEDIC INE

APPROX. PERCENTAGE OF SALES: 15%

Page 20: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

20

R I S E R E F R E S H R E S T

• BRAND ETHOS : CRESCO ELEVATES

EVERYDAY CANNABIS . HIGH QUALITY.

TRUE CONSISTENCY. REMARKABLE

VALUE. CRESCO IS CANNABIS YOU CAN

COUNT ON THAT DEL IVERS

CONSISTENT CANNABIS PRODUCTS

EVERY T IME.

• AUDIENCE: CRESCO PRODUCTS ARE

IDEAL FOR PEOPLE WHO LOVE

TRADITIONAL CANNABIS FORMATS.

THIS IS THE CANNABIS BRAND FOR

THE STARBUCKS CUSTOMER — ABOVE

AVERAGE QUALITY BUT STILL

ACCESSIBLE TO EVERYONE.

• PRODUCT PILLARS:

-THC-FOCUSED, EVERY DAY CANNABIS

-PROPRIETARY COLOR CODED FOR

EASE OF USE

- ALWAYS IN STOCK, EVERY TIME

APPROX. PERCENTAGE OF SALES: 55%

Page 21: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

• BRAND ETHOS: CONNOISSEUR-QUALITY CANNABIS DEMANDS HIGHER

EXPECTATIONS FROM CONSUMER AND CULTIVATOR AL IKE. FOCUSED ON

EXCLUSIVE GENETICS , CULTIVATION TECHNIQUE & ATTENTION TO

DETAIL , RESERVE IS MORE THAN CANNABIS - IT ’S A L IFESTYLE.

• AUDIENCE: FANS OF RESERVE ARE HIGHLY SELECTIVE AND TURN TO

RESERVE FOR A LUXURY EXPERIENCE IN CANNABIS . THEY ARE

KNOWLEDGEABLE ABOUT CULTIVATION AND L INEAGE, EXTRACTION AND

HARDWARE. RESERVE DEL IVERS A SUPERIOR CANNABIS EXPERIENCE FOR

THOSE WHO ARE LOOKING FOR TRULY TOP SHELF CANNABIS .

• PRODUCT PILLARS:

-HAND-SELECTED STRAINS & PROPRIETARY GENETICS

-CONNOISSEUR CONCENTRATES & VAPE PENS

-TERPENE-RICH, THC FORWARD PRODUCTS

APPROX. PERCENTAGE OF SALES: 15%

Page 22: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

22

• BRAND ETHOS: HIGH QUALITY DESSERTS WITH NO CANNABIS FLAVOR,

CREATED BY THE ACCLAIMED PASTRY CHEF, MINDY SEGAL

• AUDIENCE: LOVERS OF DECADENT, CHOCOLATE-FORWARD, EDIBLE

FORMS OF CANNABIS , WHO WILL PAY A PREMIUM FOR SUPERIOR

PRODUCTS

• PRODUCT PILLARS:

- INFUSED WITH ODORLESS, FLAVORLESS DISTILLATE

-DECADENT DESSERTS INSPIRED BY MINDY’S RESTAURANTS

-EXCELLENT GIFT OR REPLACEMENT FOR WINE AT DINNER PARTIES

• Approx. Percentage of Sales: 5%

• BRAND ETHOS: FUN, FRUITY CONFECTIONS FOR EVERYDAY

ENJOYABIL ITY AND EFFECTIVENESS

• AUDIENCE: CONSUMERS THAT WANT A FUN AND APPROACHABLE TREAT

FROM A HIGH QUALITY PRODUCER

• PRODUCT PILLARS:

- INFUSED WITH WINTERIZED SATIVA, INDICA AND HYBRID OILS

-FUN, FRUITY FLAVORS

-GREAT QUALITY AND CONSISTENCY AT AN ACCESSIBLE PRICE POINT

• Approx. Percentage of Sales: 10%

Page 23: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

MARKETING STRATEGY

• Awareness and education via out of home, social

media, and other channels equip consumers with

functional knowledge of the science and utility of

cannabis.

• Industry programming via patient help centers,

physician CME events, and robust informational

materials educate patients and the public.

Awareness & Education In-Store Experience Outreach

• A multi-brand product suite caters to unique

consumer needs and buyer profiles.

• Packaging designed to feature proprietary, benefit-

forward communication is informative and intuitive.

• Collateral, merchandising materials, sales

promotions, public marketing, and retail partner

management all contribute to the sales funnel.

• Key influencers help Cresco brands reach wider

audiences via social media and exclusive events.

• The nation-wide industry brand ambassador club offers

behind-the-scenes product access and release events.

• Dedicated customer service teams funnel product

feedback to quality assurance and other key functions.

23

Page 24: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

24

100%M A RKE T P E N E TRA TI ON

+28%(1)

M A RKE T SH A RE

100%M A RKE T P E N E TRA TI ON

+30%(2)

M A RKE T SH A RE

WE DRIVE WHOLESALE DISTRIBUTION EFFECTIVENESS

100%M A RKE T P E N E TRA TI ON M A RKE T SH A RE

TBD

(1) BASED ON DATA PROVIDED BY THE STATE OF ILLINOIS

(2) BASED ON DATA OBTAINED DIRECTLY FROM PA DISPENSARIES

Page 25: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

RETAILINSIGHTS

DESIGN &DEVELOP

TEST &VALIDATE

OUR CAPABILITIES ALLOW US TO INNOVATE, LEARN, AND SCALE RAPIDLY

New Brands & Formats

Technology

Intellectual Property

New Product/Brand

Trials

Evaluation and

Improvements

Consumer Awareness

Trend Forecasting

Consumer Behaviors

Multi-states Access

Marketing Awareness

Continued Consumer and

Patient Feedback

SCALE

25

Page 26: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

SUSTAINABLE FINANCIAL PERFORMANCE

Q3 & YTD 2018 FINANCIAL RESULTS

NOTE: EBITDA IS A NON-IFRS MEASURE. PLEASE REFER TO

INVESTORS.CRESCOLABS.COM FOR THE DEFINITION

$16.3M

PROFORMA REVENUE

+335% YOY

$3.9M

NET INCOME

UP COMPARED TO A NET

LOSS OF $0.2M IN Q3 2017

$5.3M

ADJ. EBITDA

UP COMPARED TO ADJUSTED

EBITDA OF $0.1M IN Q3 2017

YTD 2018NINE MONTHS ENDED 9/30/18

PROFORMA REVENUE

$35.1M

NET INCOME

$6.5M

ADJ. EBITDA

$8.1M

Q3 2018THREE MONTHS ENDED 9/30/18

+248% YOY UP COMPARED TO A NET

LOSS OF $0.9M IN YTD 2017

UP COMPARED TO ADJUSTED

EBITDA OF -$0.8M IN YTD 2017

26

Page 27: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

27

• On December 6th, 2018, Cresco Labs announced a definitive agreement to acquire 100% membership interests of Hope Heal Health, based in Massachusetts with licences for

cultivation, processing, and the ability to obtain up to three medical marijuana dispensary licenses and three adult-use dispensary licenses.

• On December 7th, 2018 Cresco Labs announced three new marketing appointments to accelerate the aspiration to become the leading brand builder within the cannabis

industry, those hires include: Greg Butler as CMO, former Vice President of Growth Strategy and Marketing for MillerCoors, Cory Rothchild as Vice President of Brand

Marketing, former Vice President and Brand Director for Gatorade, and Chis Rivera as Vice President of Marketing, formerly of Senior Director of MillerCoors Craft division.

• On December 12th, 2018 Cresco Labs announced that Co-founder and CEO, Charles Bachtell, was appointed to the Cannabis Legalization Subcommittee of Illinois Governor-

elect JB Pritzker’s transition team to lead the efforts for adult use legalization.

• On December 12th, 2018, Cresco Labs announced that it had been granted the first approval to operate a marijuana dispensary in the state of Ohio.

• On December 19th, 2018, Cresco Labs announced that it had been awarded a second merit-based license for dispensary operations in Pennsylvania which allows us to open

three additional dispensary locations.

• On December 20th, 2018, Cresco Labs announced that it had signed dual definitive agreements to acquire licensed Illinois medical cannabis dispensaries MedMar Rockford

and MedMar Lakeview bringing our total number of dispensaries in Illinois to five.

• On January 16th, 2019, Cresco Labs announced that it had made the first legal sale of medical marijuana in the state of Ohio.

• On January 28th, 2019, Cresco Labs announced that it had appointed Dun & Bradstreet CEO Tom Manning as Chairman of its Board of Directors. Mr. Manning has been a

member of Cresco Labs' board since 2016 and was formerly the CEO of Cerberus Capital Asia, Capgemini Asia, and Ernst & Young Consulting Asia and was also a senior partner

at Bain & Company.

• On January 30, 2019, Cresco Labs opened a manufacturing facility and two dispensaries in the state of New York.

• On February 1, 2019, the IL program implemented the Alternative to Opioids Act which removed finger printing, background checks and provides same day access for patients.

• On February 5, 2019, Cresco Labs announced that its Mindy’s Kitchen brand has been ranked the top selling edible in Nevada according to Headset.

• On February 25, 2019, Cresco Labs announced the formation of a new hemp CBD subsidiary, Well Beings, that will provide the Company the ability to expand its house of

branded products to all 50 states to potentially reach a new customer base outside of the licensed dispensary channel.

• On February 26, Cresco Labs announced the opening of a third Pittsburgh area dispensary and launched online ordering in Western Pennsylvania.

• As of February 28th, 2019, Cresco Labs stock is up over 50% from the launch price.

RECENT BUSINESS DEVELOPMENTS

Page 28: MANAGEMENT PRESENTATION MARCH 2019s22.q4cdn.com/545881950/files/doc_presentations/2019/03/Cresco... · q3 & ytd 2018 financial results note: ebitda is a non-ifrs measure. please refer

THANK YOU